Vimarsana
Biggest News Aggregation in the World

Ve Psyb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ve Psyb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ve Psyb Today - Breaking & Trending Today

PsyBio Therapeutics Corp files provisional patent for producing psilocybin with the US Patent and Trademark Office - Vimarsana News

PsyBio Therapeutics Corp files provisional patent for producing psilocybin with the US Patent and Trademark Office

PsyBio Therapeutics files provisional patent for producing psilocybin with the US Patent and Trademark Office The filing increases the company's licensed patent portfolio to four pending provisional patents and one pending non-provisional patent with the US Patent and Trademark Office The patent application was titled 'Optimized Methods for the Production of Psilocybin and its Intermediates or Side Products' PsyBio Therapeutics Corp (CVE:PSYB) (OTCPINK:PSYBF) said it has filed a provisional patent application with the US Patent and Trademark Office (USPTO), titled 'Optimized Meth...

PsyBio Therapeutics Corp and Miami University broaden partnership agreement to advance its neuropsychiatric drug discovery platform - Vimarsana News

PsyBio Therapeutics Corp and Miami University broaden partnership agreement to advance its neuropsychiatric drug discovery platform

PsyBio and Miami University broaden partnership agreement to advance its neuropsychiatric drug discovery platform The McMurray Lab in Miami University plans to conduct IND-enabling, animal studies to verify the antidepressant, anti-addictive effects of the alkaloids produced in the Jones Lab The collaboration with Miami University is “anticipated to expediate progress" towards the filing of an IND application with the US FDA PsyBio Therapeutics Corp (CVE:PSYB) (FRA:PSYB) announced that it has amended its master-sponsored agreement with Miami University based in Oxford, Ohio for ...